Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
äŒæ¥ã³ãŒãELAN
äŒç€ŸåElanco Animal Health Inc
äžå Žæ¥Sep 20, 2018
æé«çµå¶è²¬ä»»è
ãCEOãSimmons (Jeffrey N)
åŸæ¥å¡æ°9000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Sep 20
æ¬ç€Ÿæåšå°450 Elanco Circle
éœåžINDIANAPOLIS
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·46221
é»è©±çªå·18773526261
ãŠã§ããµã€ãhttps://www.elanco.com/
äŒæ¥ã³ãŒãELAN
äžå Žæ¥Sep 20, 2018
æé«çµå¶è²¬ä»»è
ãCEOãSimmons (Jeffrey N)